Press Releases: Page 10
Post a press release | Manage press releases
-
Emerald Clinical Trials Confirms CEO Transition and Continuity Plan
Press release from Emerald Clinical Trials • July 30, 2025 -
Altanine Names Charles J. Andres, Ph.D., J.D., as CEO to Lead Clinical and Strategic Expansion
Press release from Altanine, Inc. • July 29, 2025 -
Diorasis Therapeutics and Northway Biotech Announce Partnership for the Development and Manufacturing of AAV Gene Therapy for Glaucoma
Press release from Northway Biotech • July 29, 2025 -
SVD to conduct two major online auctions for the assets of Oakbio and ShangPharma Innovation
Press release from Silicon Valley Disposition • July 28, 2025 -
START and Advarra Unite to Deliver Unmatched Speed, Quality, and Predictability for Early-Phase Oncology Trials
Press release from The START Center for Cancer Research • July 24, 2025 -
Lutroo Imaging Granted FDA Fast Track Designation for Radiocaine™, a PET Radiotracer for Pain Imaging
Press release from Lutroo Imaging • July 23, 2025 -
Clintrex Expands Its Regulatory Leadership Team
Press release from Clintrex Research LLC • July 22, 2025 -
Cycle Pharmaceuticals Selects LeMed Specialty Pharmacy as Exclusive U.S. Specialty Pharmacy Distribution and Services Partner for HARLIKU™ (nitisinone) Tablets
Press release from LeMed Specialty Pharmacy • July 21, 2025 -
Uniphar Rebrands On Demand Business to Uniphar Global Sourcing, Strengthening Global Pharmaceutical Offering
Press release from Uniphar • July 17, 2025 -
Trialt Names Dr. Yuri Kartashov as Chief R&D Officer to Reinforce Strong Biostatistics and Clinical Data Leadership at the Global CRO
Press release from Trialt • July 15, 2025 -
4B Technologies Announces Phase 1 Trial Results for 4B03-04, a Potential First-in-Class Non-Opioid Therapy for Chronic Pain
Press release from 4B Technologies • July 13, 2025 -
Woven Health Collective Acquires Boundless Life Sciences Group to Expand Digital and Creative Marketing Capabilities
Press release from Woven Health Collective • July 9, 2025 -
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review
Press release from ProPharma • July 8, 2025 -
Not Just a Patch earns FDA, EU clearance for CGM patches line, expanding diabetes support offerings
Press release from Not Just a Patch • July 4, 2025 -
Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001
Press release from Neurizon Therapeutics • July 3, 2025 -
Nobel Laureate Morten Meldal Joins Receptor.AI as Scientific Advisor
Press release from Receptor.AI • July 2, 2025 -
Lutroo Imaging Begins Phase 1 Clinical Trial of Radiocaine™, a First-in-Class PET Radiotracer for Pain Imaging and Diagnosis
Press release from Lutroo Imaging • July 1, 2025 -
Noah AI Launches Specialized AI Agent to Empower Biomedical Professionals with Intelligent Insights
Press release from Noah AI • June 30, 2025 -
Transcenta Strengthens Osemitamab Promise for G/GEJ Cancer with OS Data from First-Line Triple Combo Trial
Press release from Transcenta • June 25, 2025 -
Vial Announces Dosing of First Participants in Phase 1 Healthy Volunteer Trial of a Novel Subcutaneous Half-Life Extended Anti-TL1A Antibody
Press release from Vial • June 25, 2025
Previous
To find more content, use the "Topics" in the menu above.
